Faculty who have authored publication Imatinib use either pre- or post-allogeneic hematopoietic cell transplantation (allo-HCT) does not increase cardiac toxicity in chronic myelogenous leukemia patients.
Name | Title | Department | Institution |
---|---|---|---|
Michael James Burke MD | Professor | Pediatrics | Medical College of Wisconsin |